UV induces common cutaneous amyloid-like melanosomal protein aggregates

Insights

Melanosomal proteinopathy, involving alpha-synuclein aggregates, contributes to skin hyperpigmentation and aging. UV light worsens this, but melanocytes use autophagy to clear aggregates, a key tanning function.

Area of Science:

  • Dermatology
  • Molecular Biology
  • Neuroscience

Background:

  • Proteinopathies, like Parkinson's disease, involve protein misfolding and aggregation.
  • Alpha-synuclein is implicated in neurodegenerative proteinopathies.
  • Melanosomal protein PMEL forms physiologic scaffolds but can ectopically accumulate in skin hyperpigmentation.

Purpose of the Study:

  • To investigate the role of melanocytic alpha-synuclein and protein aggregation in cutaneous pigmentary disorders.
  • To explore the mechanisms of protein aggregate formation and clearance in melanocytes.
  • To identify potential therapeutic targets for melanocyte dysfunction.

Main Methods:

  • Molecular, proteomic, and electron microscopic analyses of clinical samples and cell/mouse models.
  • Real Time Quaking-Induced Conversion Assay (RT-QuIC) to assess protein self-propagation.
  • CUT&RUN chromatin profiling and single-cell RNA-seq to study gene regulation and cellular processes.

Main Results:

  • Melanocytic alpha-synuclein forms intracellular aggregates similar to those in Parkinson's disease and extracellular deposits in hyperpigmentation.
  • UV radiation induces self-propagation of misfolded melanosomal proteins in a prion-like manner.
  • Melanocytes use MITF-regulated autophagy to remove aggregates, identifying aggregate clearance as a core tanning function.
  • Impaired intracellular aggregate removal leads to melanocyte senescence, exacerbating hypopigmentation and photoaging.

Conclusions:

  • Melanosomal proteinopathy is a common factor in melanocyte dysfunction and pigmentary disorders.
  • Aggregate removal is a critical function of melanocytes, particularly during tanning.
  • Targeting protein aggregate management offers a potential therapeutic strategy for melanocyte dysfunction and related skin conditions.